Company Filing History:
6 out of 1,973 
1 out of 832,761 Years Active: 1987-1999
Title: The Innovative Contributions of Charles Frederick Morris
Introduction
Charles Frederick Morris, an accomplished inventor based in Newbury Park, California, holds an impressive portfolio of seven patents. His innovative work primarily focuses on therapeutic applications of keratinocyte growth factor (KGF), demonstrating significant advancements in medical science.
Latest Patents
Morris's most recent patents revolve around the therapeutic uses of keratinocyte growth factor. Extensive in vivo studies conducted in animal models have unveiled that KGF stimulates the proliferation, growth, and differentiation of various cells within epithelial tissue, extending beyond keratinocytes. This enhanced understanding of KGF's biological effects in vivo opens avenues for its utilization as a therapeutic agent. Formulated within pharmaceutical compositions, KGF is poised for specific treatments targeting disease states and medical conditions affecting diverse tissues and organs, including the dermal adnexae, liver, lungs, and gastrointestinal tract.
Career Highlights
Throughout his career, Morris has made significant contributions to the field of biomedical innovation. His collaboration with leading companies like Amgen Inc. showcases his dedication to research and development within the biotechnology sector. His extensive work on KGF has established him as a pioneering figure in therapeutic advancements.
Collaborations
Morris has collaborated with notable individuals in his field, including Glenn Francis Pierce and Regina Mae Housley. Working alongside such esteemed professionals has undoubtedly contributed to the depth and impact of his research endeavors.
Conclusion
Charles Frederick Morris stands out as a prominent inventor in the arena of therapeutic innovations. With a clear focus on keratinocyte growth factor and its potential medical applications, his work promises significant benefits in treating various tissue-related diseases. As he continues to drive forward research and innovation, the influence of his contributions will likely be felt for years to come.